For the Quarter Ending March 2026
Gentamicin Sulphate Prices in North America
- In United States, the Gentamicin Sulphate Price Index fell quarter-over-quarter in Q1 2026, as Chinese suppliers lowered global prices.
- The Gentamicin Sulphate Production Cost Trend rose during March 2026, driven by a 4.0% PPI and 3.3% CPI.
- Industrial production grew 0.7% while the Manufacturing Index expanded in March 2026, supporting steady pharmaceutical formulation activity.
- The Gentamicin Sulphate Demand Outlook strengthened in March 2026, supported by 4.0% retail sales growth and 4.3% unemployment.
- Consumer confidence reached 91.8 in March 2026, boosting veterinary applications while pharmaceutical ingredient onshoring strengthened.
- Soybean meal and corn glucose feedstock futures fluctuated before strengthening in March 2026, elevating fermentation expenses.
- Natural gas energy costs trended upward in Q1 2026, pressured by rising power generation demand and cold weather.
- The Gentamicin Sulphate Price Forecast and Gentamicin Sulphate Price Index reflected downward pressure in Q1 2026 from imports.
Why did the price of Gentamicin Sulphate change in March 2026 in North America?
- Chinese suppliers significantly lowered global active pharmaceutical ingredient prices in Q1 2026 ahead of tariffs.
- Domestic soybean meal and corn glucose feedstock costs strengthened during March 2026, pressuring production margins.
- Generic antibiotic demand expanded significantly across the broader United States pharmaceutical market during Q1 2026.
Gentamicin Sulphate Prices in APAC
- In China, the Gentamicin Sulphate Price Index rose quarter-over-quarter in Q1 2026, driven by production costs.
- Producer Price Index rose 0.5% and industrial production expanded 5.7% in March 2026, impacting the Gentamicin Sulphate Production Cost Trend.
- Consumer Price Index grew 1.0% while retail sales rose 1.7% in March 2026, stabilizing the Gentamicin Sulphate Demand Outlook.
- Unemployment hit 5.4% in March 2026 and consumer confidence reached 91.6 in February 2026, limiting discretionary spending.
- Soybean meal feedstock costs surged in Q1 2026, driving up fermentation expenses for regional antibiotic manufacturers.
- Institutional hospital procurement demands for antibiotics remained resilient throughout Q1 2026, bolstering the Gentamicin Sulphate Price Forecast.
- Domestic soybean meal feedstock inventories plummeted in March 2026 as import volumes contracted sharply in February 2026.
- Transportation and logistics costs spiked in March 2026, elevating operational expenses for domestic pharmaceutical producers.
Why did the price of Gentamicin Sulphate change in March 2026 in APAC?
- Soybean meal feedstock costs and transportation expenses surged significantly across the region in Q1 2026.
- Institutional hospital procurement demands for active pharmaceutical ingredients remained highly resilient throughout entire Q1 2026.
- The Producer Price Index rose 0.5% in March 2026, reflecting increased factory-gate chemical manufacturing costs.
Gentamicin Sulphate Prices in Europe
- In Germany, the Gentamicin Sulphate Price Index rose quarter-over-quarter in Q1 2026, driven by surging energy costs.
- The Gentamicin Sulphate Production Cost Trend increased as Germany recorded a 2.7% CPI rise in March 2026.
- Conversely, producer prices recorded -0.2% in March 2026, slightly easing upstream chemical reagent expenses locally.
- The Manufacturing Index expanded in March 2026, supporting a positive Gentamicin Sulphate Demand Outlook across sectors.
- Industrial production remained stagnant at 0.0% in February 2026, limiting broader pharmaceutical supply chain expansion.
- Retail sales grew by 0.7% in February 2026, sustaining steady consumer purchases of over-the-counter pharmacy goods.
- A stable 4.2% unemployment rate in February 2026 ensured continued household spending on essential healthcare medications.
- Consumer confidence dropped to -24.7 in March 2026, delaying non-essential veterinary care and elective medical procedures.
- The Gentamicin Sulphate Price Forecast remained elevated in Q1 2026 due to tightened local inventories and congestion.
Why did the price of Gentamicin Sulphate change in March 2026 in Europe?
- European natural gas benchmark prices spiked in March 2026, significantly increasing industrial fermentation energy costs.
- North European seaport congestion delayed pharmaceutical processing, tightening available local chemical inventories during March 2026.
- Import transit times to Germany lengthened in Q1 2026 as vessels circumvented western shipping disruptions.
For the Quarter Ending December 2025
Gentamicin Sulphate Prices in North America
- In the United States, the Gentamicin Sulphate Price Index rose quarter-over-quarter in Q4 2025, driven by increased production costs and strengthening demand.
- Production costs for Gentamicin Sulphate increased, with CPI rising 2.7% year-over-year in December 2025.
- Producer Price Index climbed 3.0% year-over-year in November 2025, indicating higher input costs for manufacturers.
- Industrial production expanded 2.0% year-over-year in December 2025, supporting veterinary and cell culture demand.
- Retail sales increased 3.3% year-over-year in November 2025, boosting human and pet veterinary medicine demand.
- Medical care and prescription drugs indices strengthened in December 2025, driving overall demand for the chemical.
- A 4.4% unemployment rate in December 2025 supported consumer spending, despite declining consumer confidence.
- Utilities output climbed in December 2025, contributing to energy-related production costs for Gentamicin Sulphate.
- Manufacturing output slightly weakened in Q4 2025, affecting overall production dynamics for the chemical.
Why did the price of Gentamicin Sulphate change in December 2025 in North America?
- Producer Price Index rose 3.0% year-over-year in November 2025, increasing manufacturing expenses.
- Consumer Price Index increased 2.7% year-over-year in December 2025, raising overall operational costs.
- Industrial production expanded 2.0% year-over-year in December 2025, boosting end-use applications.
Gentamicin Sulphate Prices in APAC
- In China, the Gentamicin Sulphate Price Index fell quarter-over-quarter in Q4 2025, influenced by producer price deflation.
- Gentamicin Sulphate production costs declined in December 2025, as the Producer Price Index fell 1.9% year-over-year.
- Demand for Gentamicin Sulphate was supported by an expanding Manufacturing Index in December 2025, indicating industrial growth.
- Overall Gentamicin Sulphate demand outlook was mixed in Q4 2025, due to weak retail sales growth of 0.9% in December 2025.
- Strong industrial production, which rose 5.2% year-over-year in December 2025, supported pharmaceutical ingredient demand.
- Consumer confidence cooled in Q4 2025, contributing to subdued consumer spending and impacting healthcare demand.
- China maintained robust supply capacity for antibiotic ingredients, with API export scales increasing through November 2025.
- The low Consumer Price Index of 0.8% in December 2025 indicated weak inflationary pressure, limiting pricing power.
Why did the price of Gentamicin Sulphate change in December 2025 in APAC?
- Producer Price Index fell 1.9% in December 2025, indicating lower input costs.
- Weak retail sales growth of 0.9% in December 2025 suggested subdued consumer demand.
- An expanding Manufacturing Index in December 2025 supported industrial activity and demand.
Gentamicin Sulphate Prices in Europe
- In Germany, the Gentamicin Sulphate Price Index fell in Q4 2025, driven by weakening feedstock costs and declining industrial producer prices.
- Gentamicin Sulphate production costs declined in Q4 2025, as the Producer Price Index (PPI) decreased by 2.5% year-over-year in December 2025.
- Liquid glucose feedstock costs weakened during November-December 2025 due to ample buyer inventories and reduced procurement.
- The Manufacturing Index showed a contracting trend in December 2025, indicating a slowdown in economic activity.
- Consumer confidence remained pessimistic at -17.5 in December 2025, impacting demand for non-essential veterinary treatments.
- Demand for Gentamicin Sulphate was supported by Germany's pharmaceutical market growth in 2025, influenced by an aging population.
- Industrial production in Germany grew by 0.8% year-over-year in October 2025, supporting stable supply chain operations.
- The Gentamicin Sulphate Price Forecast indicates continued pressure from lower input costs and cautious consumer spending into early 2026.
Why did the price of Gentamicin Sulphate change in December 2025 in Europe?
- Producer Price Index (PPI) declined by 2.5% year-over-year in December 2025, reducing overall production costs.
- Liquid glucose feedstock costs weakened in November-December 2025 due to sufficient buyer inventories.
- Consumer confidence was significantly pessimistic at -17.5 in December 2025, dampening discretionary spending.
For the Quarter Ending September 2025
Gentamicin Sulphate Prices in North America
- In United States, Gentamicin Sulphate Price Index rose in Q3 2025, driven by increasing production costs.
- Production costs increased in Q3 2025, influenced by rising industrial electricity prices in September 2025.
- Demand was supported by strengthened US consumer spending on healthcare in September 2025.
- The Price Index reflected upward pressure from a 3.0% year-over-year CPI increase in September 2025.
- A 2.6% year-over-year PPI increase in August 2025 signaled higher input costs for manufacturing.
- Demand outlook bolstered by a 5.42% year-over-year increase in retail sales in September 2025.
- Manufacturing backlogs and inventories continued to shrink in Q3 2025, impacting supply chain efficiency.
- Low unemployment at 4.3% in September 2025 supported healthcare spending, influencing demand.
- Upward pressure on natural gas prices in Q3 2025 contributed to higher production expenses.
Why did the price of Gentamicin Sulphate change in September 2025 in North America?
- Industrial electricity prices increased in September 2025, raising Gentamicin Sulphate production costs.
- US consumer spending on healthcare strengthened in September 2025, boosting Gentamicin Sulphate demand.
- A 3.0% year-over-year CPI increase in September 2025 elevated overall operational expenses.
Gentamicin Sulphate Prices in APAC
- In China, the Gentamicin Sulphate Price Index fell in Q3 2025, influenced by a -2.3% PPI year-on-year in September.
- Gentamicin Sulphate production costs were mixed in Q3 2025, with softening sugar feedstock and slightly rising industrial electricity.
- Demand for Gentamicin Sulphate was supported by a 6.5% year-on-year increase in industrial production in September 2025.
- The Manufacturing Index contracted in September 2025, impacting overall industrial activity and API demand.
- Retail sales grew 3.0% year-on-year in September 2025, supporting demand for human and veterinary medicine products.
- Persistent overcapacity in China's chemical industry exerted downward pressure on Gentamicin Sulphate pricing in Q3 2025.
- Growing demand for pharmaceutical products among the geriatric population drove Gentamicin Sulphate consumption in Q3 2025.
- China's consumer confidence index of 89.6 in September 2025 reflected pessimistic sentiment, impacting discretionary healthcare spending.
Why did the price of Gentamicin Sulphate change in September 2025 in APAC?
- Falling factory-gate prices, with PPI at -2.3% year-on-year in September 2025, reduced pricing power.
- Persistent overcapacity in China's chemical industry created downward pressure on prices in Q3 2025.
- A contracting Manufacturing Index in September 2025 signaled reduced industrial activity, impacting API demand.
Gentamicin Sulphate Prices in Europe
- In Germany, the Gentamicin Sulphate Price Index faced downward pressure in Q3 2025, as industrial production contracted (-1.0% in September 2025).
- Gentamicin Sulphate production costs remained elevated in Q3 2025, driven by high raw material and electricity prices.
- The Gentamicin Sulphate demand outlook was challenged by a contracting Manufacturing Index in September 2025.
- Germany's pharmaceutical market expanded moderately in Q3 2025, supporting Gentamicin Sulphate demand.
- Rising CPI (2.4% in September 2025) increased operational costs, while PPI (-1.7%) eased raw material pressures.
- Low unemployment (3.9% in September 2025) indirectly supported healthcare spending, despite low consumer confidence (-23.6).
- Modest retail sales growth (0.8% in September 2025) offered slight support to the broader economic environment.
- The Gentamicin Sulphate Price Forecast suggests continued pressure from high energy costs and weak industrial output.
Why did the price of Gentamicin Sulphate change in September 2025 in Europe?
- Contracting industrial production (-1.0% in September 2025) reduced overall demand for chemical inputs.
- Elevated electricity and natural gas prices in Q3 2025 sustained high Gentamicin Sulphate production costs.
- Mixed inflation signals, with rising CPI (2.4%) and falling PPI (-1.7%) in September 2025, impacted costs.
